Due to shifting regulations at the beginning of the COVID-19 pandemic, more telehealth services were available to patients. Our team saw this as an opportunity to create a system to virtually prescribe buprenorphine to patients with OUD. As a result, treatment for substance use is more accessible to patients.
Members of our staff were interviewed about their experiences with the Warmline and some of the barriers and facilitators to the program. This article highlights how our program is crucial to addressing gaps in the healthcare system.